Neuroscience
Page 1 • 2 itemsUnlock global neuroscience pharma market insights. Discover drug development, clinical trials, and investment opportunities in CNS therapeutics.
Contineum Therapeutics PIPE-791 Shows Positive Phase 1b Results for Chronic Osteoarthritis Pain
Contineum Therapeutics reports positive Phase 1b trial data for PIPE-791, a non-opioid LPA1 receptor antagonist for chronic osteoarthritis pain treatment.
Vistagen Receives FDA Approval to Advance Refisolone Phase 2 Trial for Menopause Hot Flashes
Vistagen gets FDA clearance to proceed with Phase 2 clinical development of Refisolone, an intranasal treatment for vasomotor symptoms in menopause.